SEC Filing Timeline
8-KNov 10, 2026
Earnings release · Items 2.02,9.01
10-QNov 10, 2026
Quarterly report
8-KNov 09, 2026
Material agreement · Items 1.01,7.01,8.01,9.01
424B5Nov 06, 2026
Prospectus / offering
8-KNov 05, 2026
Earnings release · Items 2.02
424B5Nov 05, 2026
Prospectus / offering
8-KNov 02, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KOct 06, 2026
Charter/bylaws amendment · Items 5.03,9.01
8-KAug 12, 2026
Earnings release · Items 2.02,9.01
10-QAug 12, 2026
Quarterly report
8-KJul 31, 2026
Material agreement · Items 1.01,8.01,9.01
424B5Jul 30, 2026
Prospectus / offering
8-KJul 29, 2026
Earnings release · Items 2.02
424B5Jul 29, 2026
Prospectus / offering
S-3Jul 02, 2026
Shelf registration
Recent News (Finnhub)
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlights: FDA Approval, Commercial ...
HC Wainwright & Co. Reiterates Buy on Inovio Pharmaceuticals, Maintains $5 Price Target
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
INOVIO to Participate in Upcoming Investor Conferences
Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $6
Inovio (INO) Q3 2026 Earnings Call Transcript
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Inovio: Q3 Earnings Snapshot